E-LIB Suche - Ergebnisse für: Lewanski, Conrad

1

Quality of Life with Second or Third LineNab-Paclitaxel-Bas..:

Ponce Aix, Santiago ; Talbot, Denis ; Govindan, Ramaswamy...
Future Oncology. 16 (2020) 12 - p. 749-762 , 2020

Link: https://doi.org/10.2217/..

2

Spatial heterogeneity of radiolabeled choline positron emis..:

Dubash, Suraiya ; Inglese, Marianna ; Mauri, Francesco...
Theranostics. 10 (2020) 19 - p. 8677-8690 , 2020

Link: https://doi.org/10.7150/..

3

The clinical role of VeriStrat testing in patients with adv..:

Lee, Siow Ming ; Upadhyay, Sunil ; Lewanski, Conrad...
European Journal of Cancer. 120 (2019) - p. 86-96 , 2019

Link: https://doi.org/10.1016/..

4

Patient Selection for Anti-PD-1/PD-L1 Therapy in Advanced N..:

Califano, Raffaele ; Lal, Rohit ; Lewanski, Conrad...
Future Oncology. 14 (2018) 23 - p. 2415-2431 , 2018

Link: https://doi.org/10.2217/..

5

P3.02b-046 Afatinib Benefits Patients with Confirmed/Suspec..:

Popat, Sanjay ; Hughes, Laura ; O'Brien, Mary...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1215-S1216 , 2017

Link: https://doi.org/10.1016/..

6

Carboplatin versus two doses of cisplatin in combination wi..:

Ferry, David ; Billingham, Lucinda ; Jarrett, Hugh...
European Journal of Cancer. 83 (2017) - p. 302-312 , 2017

Link: https://doi.org/10.1016/..

7

Atezolizumab versus docetaxel for patients with previously ..:

Fehrenbacher, Louis ; Spira, Alexander ; Ballinger, Marcus...
The Lancet. 387 (2016) 10030 - p. 1837-1846 , 2016

Link: https://doi.org/10.1016/..

8

Prophylactic radiotherapy for the prevention of procedure-t..:

Clive, Amelia O ; Taylor, Hazel ; Dobson, Lee...
The Lancet Oncology. 17 (2016) 8 - p. 1094-1104 , 2016

Link: https://doi.org/10.1016/..

9

PD‐L1 testing for lung cancer in the UK: recognizing the ch..:

Cree, Ian A ; Booton, Richard ; Cane, Paul...
Histopathology. 69 (2016) 2 - p. 177-186 , 2016

Link: https://doi.org/10.1111/..

10

Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant..:

Palmieri, Carlo ; Macpherson, Iain RJ ; Yan, Kelvin...
Oncotarget. 7 (2015) 11 - p. 13209-13220 , 2015

Link: https://doi.org/10.18632..

11

First-line erlotinib in patients with advanced non-small-ce..:

Lee, Siow Ming ; Khan, Iftekhar ; Upadhyay, Sunil...
The Lancet Oncology. 13 (2012) 11 - p. 1161-1170 , 2012

Link: https://doi.org/10.1016/..

12

ABOUND.2L+: A randomized phase 2 study of nanoparticle albu..:

Morgensztern, Daniel ; Cobo, Manuel ; Ponce Aix, Santiago...
Cancer. 124 (2018) 24 - p. 4667-4675 , 2018

Link: https://doi.org/10.1002/..

13

Treatment outcomes by histology in REVEL: A randomized phas..:

Paz-Ares, Luis G. ; Pérol, Maurice ; Ciuleanu, Tudor-Eliade...
Lung Cancer. 112 (2017) - p. 126-133 , 2017

Link: https://doi.org/10.1016/..

14

Quality of life results from the phase 3 REVEL randomized c..:

Pérol, Maurice ; Ciuleanu, Tudor-Eliade ; Arrieta, Oscar...
Lung Cancer. 93 (2016) - p. 95-103 , 2016

Link: https://doi.org/10.1016/..

15

Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy..:

Lee, Siow Ming ; Lewanski, Conrad R. ; Counsell, Nicholas...
JNCI: Journal of the National Cancer Institute. 106 (2014) 7 - p. , 2014

Link: https://doi.org/10.1093/..